Clicky

mobile btn
Monday, May 6th, 2024

Private

Armored Multi-Purpose Vehicle benefits highlighted

The Army’s Armored Multi-Purpose Vehicle (AMPV) was recently touted as a key component in delivering command and control, troop transport, mortar, medical evacuation, and medical treatment to the battlefield. Under the Armored Brigade Combat Team (ABCT) formation, officials said the AMPV,... Read More »

Technology to bolster army vehicle protections

The Army's Tank Automotive Research, Development and Engineering Center (TARDEC) recently awarded Lockheed Martin a contract to help bolster army vehicle protections. Officials said Lockheed Martin would continue developing the Modular Active Protection Systems (MAPS), which is designed to... Read More »

Raytheon eyes small drone swarms as tactical future

New technology under development by Raytheon BBN Technologies could unleash swarms of small, autonomous air and ground vehicles, working in tandem and under the control of remote operators. As part of DARPA’s Offensive Swarm-Enabled Tactics program, the company is developing technology to... Read More »

Program credited with expediting Ugandan virus detection

A Centers for Disease Control and Prevention (CDC) report is touting the benefits of a program credited with expediting Ugandan virus detection. The CDC-UVRI Viral Hemorrhagic Fever Surveillance and Laboratory Program was lauded in a CDC report published in The Lancet Infectious Diseases. The... Read More »

CDC warns travelers over Brazil Yellow Fever outbreak

An outbreak of yellow fever is ravaging Brazil, driven by mosquitoes that are now reaching popular tourist destinations typically removed from such outbreaks, and prompting a warning call from the Centers for Disease Control and Prevention (CDC). The CDC warns that travelers should be... Read More »

H7N9 influenza vaccine clinical trials underway

A pair of clinical trials sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) will test an experimental vaccine to prevent influenza caused by an H7N9 influenza virus. Officials said the Phase 2 studies would test different dosages of the inactivated influenza vaccine... Read More »

NIAID releases strategy for universal influenza vaccine

The National Institute of Allergy and Infectious Diseases (NIAID) laid out a point by point note of the necessities for a universal flu vaccine this week, publishing their strategy in the Journal of Infectious Diseases. For such a vaccine to be successful, the organization saw four main goals... Read More »